License Grants Sample Clauses

License Grants. The licenses granted in this Section 2 are subject to the terms and conditions set forth in this XXXX: a. Subject to Section 2(b), you may install and use the Software on a single computer; OR install and store the Software on a storage device, such as a network server, used only to install the Software on your other computers over an internal network, provided you have a license for each separate computer on which the Software is installed and run. Except as otherwise provided in Section 2(b), a license for the Software may not be shared, installed or used concurrently on different computers. b. In addition to the single copy of the Software permitted in Section 2(a), the primary user of the computer on which the Software is installed may make a second copy of the Software and install it on either a portable computer or a computer located at his or her home for his or her exclusive use, provided that: A. the second copy of the Software on the portable or home computer (i) is not used at the same time as the copy of the Software on the primary computer and (ii) is used by the primary user solely as allowed for such version or edition (such as for educational use only), B. the second copy of the Software is not installed or used after the time such user is no longer the primary user of the primary computer on which the Software is installed. c. In the event the Software is distributed along with other PremiumSoft software products as part of a suite of products (collectively, the "Studio"), the license of the Studio is licensed as a single product and none of the products in the Studio, including the Software, may be separated for installation or use on more than one computer. d. You may make one copy of the Software in machine-readable form solely for backup purposes. You must reproduce on any such copy all copyright notices and any other proprietary legends on the original copy of the Software. You may not sell or transfer any copy of the Software made for backup purposes. e. You agree that PremiumSoft may audit your use of the Software for compliance with these terms at any time, upon reasonable notice. In the event that such audit reveals any use of the Software by you other than in full compliance with the terms of this Agreement, you shall reimburse PremiumSoft for all reasonable expenses related to such audit in addition to any other liabilities you may incur as a result of such non-compliance. f. Your license rights under this XXXX are non-exclusive...

License Grants. The Software is offered in the following license types, as listed hereinunder during the applicable Term and in consideration of your payment of the applicable fees, and subject to the terms, conditions and restrictions set forth in this Agreement which. The license grants may be combined, pursuant to the specific grant and restrictions set forth below and for the Term noted in the Order Form. The following license types may also be available as Site, Team or Enterprise licenses if noted on the Order Form. For the avoidance of doubt, if the license type listed below is not indicated on your Order Form then it does not apply to your purchase. The license covers any updates, upgrades, or new releases, if any are provided to you by us and any copies you are permitted to make hereunder and any available Documentation. Any references to a "sale" or a "purchase" of the Software in this or any other document means "license" in accordance with the terms contained in this Agreement. You may make a reasonable number of backup copies of the Software and Documentation for internal, Non-Commercial, Non-Production use. All titles, trademarks and copyright and restricted notices in the Software must be reproduced in any copies you are permitted to make hereunder.

License Grants. The Software is offered in the following license types, which may be combined, pursuant to the specific grant and restrictions set forth below and for the Term noted in the Order Form. The following license types may also be available as Site, Team or Enterprise licenses if noted on the Order Form. For the avoidance of doubt, if the license type listed below is not indicated on your Order Form then it does not apply to your purchase. The license covers any updates, upgrades, or new releases, if any are provided to you by us and any copies you are permitted to make hereunder and any available Documentation. Any references to a "sale" or a "purchase" of the Software in this or any other document means "license" in accordance with the terms contained in this Agreement. You may make a reasonable number of backup copies of the Software and Documentation for internal, Non-Commercial, Non-Production use. All titles, trademarks and copyright and restricted notices in the Software must be reproduced in any copies you are permitted to make hereunder. As noted in the Order Form, during the applicable Term and in consideration of your payment of the applicable fees, and subject to the terms, conditions and restrictions set forth in this Agreement:

License Grants. Subject to the terms of this Agreement, M.I.T. hereby grants to COMPANY and its AFFILIATES for the TERM a royalty-bearing license under the PATENT RIGHTS to develop, make, have made, use, sell, offer to sell, lease, and import LICENSED PRODUCTS in the FIELD in the TERRITORY and to develop and perform LICENSED PROCESSES in the FIELD in the TERRITORY.

License Grants. Subject to the terms of this Agreement, Ipsen, for and on behalf of itself and all of its Affiliates, hereby grants to Licensee and its Affiliates the following rights (the “Licensed Rights”): - an exclusive (even as to Ipsen and its Affiliates) right and license in all countries of the Territory, under the Ipsen Technology and the Ipsen Joint Technology Rights, to research, develop, register, use, make, have made, import, export, market, distribute, offer for sale and sell Licensed Product in the Territory for any and all uses and fields of use (it being understood and agreed that, notwithstanding the foregoing exclusive grant to Licensee, Licensee hereby authorizes and consents to the exercise by Ipsen and its Affiliates of any and all rights under the Ipsen Technology and the Ipsen Joint Technology Rights if and to the extent necessary for the sole purpose of Ipsen performing its obligations under this Agreement), and - a non-exclusive right and license in all countries of the Territory under the Ipsen [ ]* Patent Rights (to the extent that the Ipsen [ ]* Patent Rights are not included within the Ipsen Patent Rights) to research, develop, register, use, * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. make, have made, import, export, market, distribute, offer for sale and sell Licensed Product in the Territory for any and all uses and fields of use, and - a non-exclusive right and license in all countries of the Territory, under the Ipsen Future Technology, to research, develop, register, use, make, have made, import, export, market, distribute, offer for sale and sell Licensed Product in the Territory for any and all uses and fields of use.

License Grants. (a) Any Deliverables supplied by either party as set forth in an SOW shall be used by the other party only under the license in this Section 4.3. Subject to the terms hereof, each party hereby grants the other party, under all of its Intellectual Property Rights embodied in the Deliverables supplied by such party as set forth in an SOW, a non-exclusive, revocable (as set forth below), non-transferable license to internally use any such Deliverables solely for the purpose of testing or developing the applicable Licensed Product as set forth in the SOW. In no event may the party that receives such Deliverables exercise the foregoing license to develop, make, use or sell, or otherwise distribute, any Deliverables of the other party other than for the foregoing purpose. The license granted to a party in this Section 4.3(a) shall terminate upon the earlier of (1) completion of the applicable development or testing of the Licensed Product under the applicable SOW, or (2) in the event that a party materially breaches this Agreement and such breach remains uncured, the date that is thirty (30) days after such party’s receipt of written notice of such material breach from the other party. (b) Additionally, EZchip grants to Marvell and its Affiliates, under all of EZchip’s Intellectual Property Rights embodied in the EZchip Deliverables and the Licensed Products a royalty bearing, non-exclusive, world-wide, perpetual, non-transferable license to manufacture, have manufactured, use, modify (but only if and to the extent specifically permitted in the applicable SOW), sell, support, distribute through multiple tiers of distribution, import, export and market the Licensed Products, and the applicable SOW may limit such license to sales to Identified Customers and Identified Programs (as such terms are defined in Section 9.1 below) and sales to EZchip or its Affiliates. The Royalty Fee or Fees referenced herein shall be as set forth in Exhibit F for each Licensed Product, respectively.

License Grants. (a) Subject to the terms of this Agreement, Paragon hereby grants to Oruka a royalty-bearing, exclusive (even as to Paragon and its Affiliates, subject to Paragon’s retained rights under Section 2.4) license, including the right to sublicense through multiple tiers, under the Licensed Antibody Technology to Develop, Manufacture, Commercialize, or otherwise exploit Licensed Antibodies, Derived Antibodies and Products in the Field in the Territory. (b) Subject to the terms of this Agreement, including Section 2.7, Paragon hereby grants to Oruka a royalty-bearing, non-exclusive right and license, including the right to sublicense through multiple tiers, under the Licensed Antibody Technology to Develop, Manufacture, Commercialize or otherwise exploit Multispecific Antibodies and Multispecific Products in the Field in the Territory. (c) Subject to the terms of this Agreement, Paragon hereby grants to Oruka a royalty-bearing, non-exclusive license, including the right to sublicense through multiple tiers, under the Other Licensed Patents to Develop, Manufacture, Commercialize or otherwise exploit Licensed Antibodies, Derived Antibodies, Multispecific Antibodies, Products and Multispecific Products in the Field in the Territory. (d) Subject to the terms of this Agreement, Paragon hereby grants to Oruka a royalty-bearing, non-exclusive license, including the right to sublicense through multiple tiers, under the Other Licensed Know-How to Develop, Manufacture, Commercialize or otherwise exploit (i) Licensed Antibodies, or (ii) Products, Multispecific Antibodies or Multispecific Products, in each case solely to the extent comprising or containing a Licensed Antibody, in the Field in the Territory. (e) Subject to the terms of this Agreement, Paragon hereby grants to Oruka a non-exclusive license, including the right to sublicense through multiple tiers, under the Paragon Cross License Patents to Develop, Manufacture, Commercialize or otherwise exploit the Licensed Antibodies solely in the Field in the Territory. (f) Subject to the terms of this Agreement, Oruka hereby grants to Paragon a non-exclusive license, including the right to sublicense through multiple tiers, under the Oruka Cross License Patents to Develop, Manufacture, Commercialize or otherwise exploit the Retained IL-23 Project Antibodies solely in the Territory in the therapeutic area of inflammatory bowel disease.

License Grants. 2.1 Subject to the other terms and conditions of this Agreement, the AbbVie-MPP Agreement, and AbbVie’s Collaborative and License Agreement related to the Licensed Compounds (“Collaboration Agreement”), Licensor hereby grants to Licensee: (a) a non-exclusive, non-transferable license under the Territory Patents to Exploit the Licensed Products in the Field and in the Territory; (b) a non-exclusive, non-transferable license under the AbbVie Patents to Manufacture and Develop the Licensed Compounds and Licensed Products in the Territory solely for the purpose of Commercialization of Licensed Products in the Field and in the Territory; (c) a non-exclusive, non-transferable license under the AbbVie Patents to Manufacture and Develop the Licensed Compounds and Licensed Products in the Manufacturing- Only Countries solely for the purpose of Commercialization of Licensed Products in the Field and in the Territory; (d) a non-exclusive, non-transferable license under the AbbVie Patents to sell, have sold, offer to sell, or otherwise distribute Licensed Products to Non-Territory Eligible Purchasers solely for the purpose of Commercialization of Licensed Products in the Field and in the Territory; and (e) a non-exclusive, non-transferable license under the AbbVie Patents to sell, have sold, offer to sell, or otherwise distribute Licensed Compounds solely for the purpose of Commercialization of Licensed Products in the Field and in the Territory. 2.2 The licenses granted hereunder do not include any license or other right to use any AbbVie trademark, trade name, logo or service xxxx (each, an “AbbVie Xxxx”) or any word, logo or any expression that is similar to or alludes to any AbbVie Xxxx. Licensee agrees not to Exploit any Licensed Products or Licensed Compounds that contain AbbVie Marks, including without limitation the brand name Maviret™ or Mavyret™ or any name confusingly similar thereto, or the same or confusingly similar color scheme used by AbbVie for its Mavryet™/Maviret™ pills and packaging. Licensee shall obtain AbbVie’s prior written approval, such approval not to be unreasonably withheld, of Licensees’ proposed trademark, trade dress, product markings or the color or shape of the proposed Licensed Products and will supplement with updated samples and color photographs in the event Licensee changes packaging or pill colors. If in AbbVie’s reasonable opinion, Licensee proposes to use marks, packaging, or a color scheme that is the same or confusingly simi...

License Grants. 3.1. The UiPath Community Edition Platform may be used subject to the terms located at the following web address: xxxxx://xxx.xxxxxx.xxx/developers/community-edition/license-agreement (or successor website) (the “UiPath Community Terms”). The UiPath Community Terms are incorporated herein by reference, provided that if there is any inconsistency between such terms and any terms of this Agreement, this Agreement shall prevail. 3.2. Subject to the terms of this Agreement, UiPath hereby grants to Partner a limited, non-exclusive, non- transferable, and non-sublicensable license during the Term to: (i) deliver the Courses to Students; (ii) reproduce a reasonable number of copies of the Teaching Resources for use in providing Services subject to any restrictions in the UiPath Community Edition Terms; and (iii) display and internally distribute the UiPath Teaching Resources to Students taking the Courses, provided that such resources retain all proprietary markings of UiPath. Subject to this license, the Partner may create any outputs, including but not limited to any software programs, artifacts, charts or workflow diagrams (collectively "Development Outputs"), test and execute them in non-production environments. The Partner retains all rights, including all Intellectual Property Rights, in the Development Outputs resulting from the Partner’s use of the UiPath Community Edition Platform, in accordance with this Agreement. 3.3. UiPath acknowledges that each Student may individually download the UiPath Community Edition Platform subject to the UiPath Community Terms.

License Grants. Subject to the terms and conditions of this Agreement, Vendor grants to Customer during the Term of this Agreement the nontransferable, nonexclusive worldwide right to permit Users to (a) use the Service, including the Base Components thereof, (b) display and print Customer Data, and (c) use the SaaS Materials solely in connection with the Service, all solely for Customer’s own internal business operations, provided such internal business operations shall not include commercial time-sharing, rental, outsourcing, service bureau or similar use. For purpose of this license grant, “Customer” shall include any outsourced or other third- party consultants or similar personnel supporting Customer as part of its typical business practices, acting under Customer’s direction and for whom Customer is fully responsible hereunder. Customer acknowledges and agrees that the license granted, for the items listed in this agreement, is not a concurrent user license and that the rights granted to Customer in this agreement are subject to all of the following agreements and restrictions: (i) the maximum number of Users that Customer authorizes to access the Service shall not exceed the number of licenses Customer has been granted; (ii) licenses cannot be shared or used by more than one individual User but may be reassigned from time to time to new Users who are replacing former Users who are no longer permitted to access the Service; (iii) Customer shall not license, sell, rent, lease, transfer, assign, distribute, display, host, outsource, disclose or otherwise commercially exploit or make the Service or the SaaS Materials available to any third party other than an authorized User; (iv) Customer shall not modify, make derivative works of, disassemble, reverse compile, or reverse engineer any part of the Service, including without limitation the Vendor Software and or SaaS Materials that are provided as a part thereof, or access the Service or SaaS Materials in order to build a similar or competitive product or service; (v) Customer shall not create Internet "links" to the Service or "frame" or "mirror" any part of the Service, including any content contained in the Service, on any other server or device; (vi) except as expressly stated herein, no part of the Service or SaaS Materials may be copied, reproduced, distributed, republished, downloaded, displayed, posted or transmitted in any form or by any means, including but not limited to electronic, mechanical, photocopying, ...